nt BRAF dimers: Aims to develop a panel of novel inhibitors that would serve as next generation drug development leads to inhibit BRAF in melanoma MRA Pilot Award, 2017-2020 Evripidis Gavathiotis, Albert Einstein College of Medicine MDSC recruitment as an adaptive resistance mechanism to PD-1 antibody therap